Search results
Order by most recent / most popular / relevance
Results: 1-10 of 731
Intellectual property weekly abstracts bulletin
- Borden Ladner Gervais LLP
- -
- Canada, USA
- -
- May 22 2013
The Supreme Court has dismissed Eli Lilly of Canada Inc.’s leave on the issue, as summarized by the Court, as to whether the creation by the Federal
Two recent US court decisions deal with the boundaries of patent law in the area of food technologies and computer systems
- Bereskin & Parr LLP
- -
- Canada
- -
- May 21 2013
The US Federal Circuit Court of Appeals and US Supreme Court have both issued important decisions this week on the scope of US patent law. Ten (10
Patent exhaustion does not allow a purchaser to make new copies of patented seeds
- Fasken Martineau DuMoulin LLP
- -
- Canada
- -
- May 16 2013
In a concise unanimous decision1, the Supreme Court of the United States has ruled in favor of Monsanto against a farmer who reproduced patented
Supreme Court declines to hear Eli Lilly’s “promise of the patent” appeal
- Bereskin & Parr LLP
- -
- Canada
- -
- May 16 2013
The Supreme Court of Canada denied leave to appeal today from the Federal Court of Appeal ("FCA") decision in Eli Lilly Canada Inc v Novopharm Ltd
What goes upmust come down: Viagra patent invalidated by Canadian Supreme Court
- Drinker Biddle & Reath LLP
- -
- Canada
- -
- May 13 2013
Pfizer and Teva have been fighting a legal battle over Pfizer's patent for Viagra in Canada. The first shot was fired when Novopharm Limited, now
Supreme Court of Canada denies leave to appeal in PM(NOC) judicial comity case
- Bereskin & Parr LLP
- -
- Canada
- -
- May 9 2013
The Supreme Court of Canada denied leave to appeal today from the Federal Court of Appeal ("FCA") decision in Allergan Inc. et al ats. Apotex Inc
Teva Canada Innovation v. Attorney General of Canada
- Borden Ladner Gervais LLP
- -
- Canada
- -
- May 8 2013
The Patented Medicine Prices Review Board (the PMPRB) ordered Teva to pay the Crown approximately $2.4 million for selling its product at an
Charting the phenomenal success of the Patent Prosecution Highway in Canada
- Smart & Biggar/Fetherstonhaugh
- -
- Canada
- -
- May 7 2013
The Patent Prosecution Highway (PPH) program has been a phenomenal success in Canada and has positioned the country as a highly cost-effective
USTR slams Canada over the treatment of pharmaceutical patents
- Norton Rose Canada LLP
- -
- Canada
- -
- May 6 2013
On May 1, 2013, the United States Trade Representative (“USTR”) released its annual IP report for 2013. Canada has been placed on the “Watch List"
Federal court rejects PMPRB Copaxone decision on excessive prices again
- Gowling Lafleur Henderson LLP
- -
- Canada
- -
- May 3 2013
By a decision of Justice Zinn dated April 30, 2013, the Federal Court quashed a Board's decision on excessive pricing of Copaxone - for the second
Current Search
Suggested Facets
Author
- Adrian Howard (9)
- Beverley Moore (198)
- Chantal Saunders (198)
- Jason Markwell (33)
- Kavita Ramamoorthy (28)
- Noel Courage (8)
- Paul Horbal (11)
- Paula Bremner (9)
- Scott Foster (33)
- Stephen M. Beney (8)
Firm Name
- Bereskin & Parr LLP (56)
- Borden Ladner Gervais LLP (231)
- Fasken Martineau DuMoulin LLP (42)
- Gowling Lafleur Henderson LLP (136)
- Heenan Blaikie LLP (20)
- McCarthy Tétrault LLP (23)
- Norton Rose LLP (71)
- SIM. IP Practice (26)
- Stikeman Elliott LLP (29)
- Torys LLP (13)
Jurisdiction
- Australia (4)
- Brazil (1)
- China (1)
- European Union (7)
- France (1)
- Israel (2)
- Japan (2)
- United Kingdom (6)
- USA (44)
